EFG Asset Management North America Corp. Takes $1.33 Million Position in Tempus AI, Inc. (NASDAQ:TEM)

EFG Asset Management North America Corp. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 38,123 shares of the company's stock, valued at approximately $1,333,000.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. TD Cowen assumed coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a "buy" rating and a $50.00 target price on the stock. Piper Sandler started coverage on shares of Tempus AI in a research report on Monday, August 12th. They issued a "neutral" rating and a $40.00 price objective on the stock. Longbow Research started coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a "buy" rating and a $48.00 target price for the company. Morgan Stanley began coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an "overweight" rating and a $44.00 target price for the company. Finally, William Blair began coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set an "outperform" rating for the company. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $45.56.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded down $4.44 during trading on Monday, reaching $60.51. 1,041,835 shares of the stock were exchanged, compared to its average volume of 1,242,231. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $77.00. The company has a 50-day moving average price of $40.37.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to analysts' expectations of $159.10 million. Analysts predict that Tempus AI, Inc. will post -6.51 earnings per share for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.